Novartis AG, the drugmaker that plans to launch four major medicines, will open a US$100 million research center in Shanghai next year to attract Chinese talent to replenish its product pipeline.
The site, set to become the eighth in the company's research network, will be staffed by scientists recruited from Shanghai-based institutions, Novartis said yesterday.
The new facility will allow the company to benefit from the growing number of highly skilled Chinese scientists, chief executive officer Daniel Vasella said. That may give the Basel, Switzerland-based company an advantage in finding new products at a time when best-selling drugs are going off-patent and research costs soar.
"The most important aspect is that in Shanghai there is a pool of scientific talent emerging," Vasella said in a telephone interview on Sunday.
The site will also help Novartis build contacts to research institutions and doctors in a key market. Worldwide drug sales will rise 5 percent to 6 percent next year to as much as US$685 billion, according to a report last month by research firm IMS Health Inc. China will be one of the fastest-growing markets, increasing 15 percent to 16 percent to about US$16 billion next year.
In China about 85 percent of people pay for drugs themselves, so makers aren't pressured by insurers or the government to lower prices as much as in other parts of the world.
Swiss rival Roche Holding AG runs two factories and one research facility in China. Roche said China revenue is estimated to reach 400 million Swiss francs (US$319 million) this year, driven by sales of the drugs.
In May, AstraZeneca Plc, the UK's second-largest drugmaker, said it would spend US$100 million in the next three years on research in China.
Novartis plans to introduce new treatments for diabetes, cancer and two for hypertension. Analysts expect the products each to bring sales of more than US$1 billion a year. The shares have outpaced larger rivals GlaxoSmithKline Plc and Sanofi-Aventis SA because of growth in heart drug Diovan and tumor-busting Gleevec.
Scientists at the Novartis center will study diseases including cancers caused by infections. Experts estimate hepatitis-induced liver cancer causes the death of 300,000 people in China each year.
The institute will open a smaller facility in May next year, the company said, before starting work on laboratories for 400 scientists.
The center will be headed by En Li, a native of Shanghai who now works at Novartis' Boston research site. The institute will also draw native Chinese returning from abroad, Fishman said.
It may take three years before the performance of the research can be reviewed, and about 12 to 15 years for it to develop new medicines, Vasella said. A similar research institute in India is "unlikely," Vasella said.
Novartis' predecessor Ciba opened its first office in Shanghai in 1938 to sell dyes, and the company is the fourth-largest supplier to Chinese hospitals. Novartis collaborates with the Shanghai Institute of Materia Medica to test traditional medicines, among other partnerships.
The Republic of China (ROC) is celebrating its 114th Double Ten National Day today, featuring military parades and a variety of performances and speeches in front of the Presidential Office in Taipei. The Taiwan Taiko Association opened the celebrations with a 100-drummer performance, including young percussionists. As per tradition, an air force Mirage 2000 fighter jet flew over the Presidential Office as a part of the performance. The Honor Guards of the ROC and its marching band also heralded in a military parade. Students from Taichung's Shin Min High School then followed with a colorful performance using floral imagery to represent Taiwan's alternate name
The Ministry of the Interior (MOI) is to tighten rules for candidates running for public office, requiring them to declare that they do not hold a Chinese household registration or passport, and that they possess no other foreign citizenship. The requirement was set out in a draft amendment to the Enforcement Rules of the Public Officials Election and Recall Act (公職人員選舉罷免法 ) released by the ministry on Thursday. Under the proposal, candidates would need to make the declaration when submitting their registration forms, which would be published in the official election bulletin. The move follows the removal of several elected officials who were
COGNITIVE WARFARE: Chinese fishing boats transmitting fake identification signals are meant to test Taiwan’s responses to different kinds of perceived incursions, a report said Chinese vessels are transmitting fake signals in Taiwan’s waters as a form of cognitive warfare, testing Taipei’s responses to various types of incursions, a report by the Institute for the Study of War said on Friday. Several Chinese fishing vessels transmitted fake automatic identification system (AIS) signals in Taiwan’s waters last month, with one mimicking a Russian warship and another impersonating a Chinese law enforcement vessel, the report said. Citing data from Starboard Maritime Intelligence, the report said that throughout August and last month, the Chinese fishing boat Minshiyu 06718 (閩獅漁06718) sailed through the Taiwan Strait while intermittently transmitting its own AIS
CHINESE INFILTRATION: Medical logistics is a lifeline during wartime and the reported CCP links of a major logistics company present a national security threat, an expert said The government would bolster its security check system to prevent China from infiltrating the nation’s medical cold chain, a national security official said yesterday. The official, who wished to stay anonymous, made the remarks after the Chinese-language magazine Mirror Media (鏡周刊) reported that Pharma Logistics (嘉里醫藥物流) is in charge of the medical logistics of about half of the nation’s major hospitals, including National Taiwan University Hospital and Taipei Veterans General Hospital. The company’s parent, Kerry TJ Logistics Co (嘉里大榮物流), is associated with the National Committee of the Chinese People’s Political Consultative Conference (CPPCC) and the Chinese People’s Liberation Army (PLA), the
RSS